arrow
G

Gregory Chlouverakis

school of medicine
H指数:30
被引数:3,570

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Defining obstruction in COPD: do fixed ratio and lower limit of normal criteria reflect different clinical characteristics? findings from a Greek cross-sectional study (EMENO)

定义COPD的阻塞: 固定比率和正常标准的下限是否反映了不同的临床特征?希腊横断面研究 (EMENO) 的发现

2026-01-150
OAAI
Cardiac remodeling and arterial stiffness progression in wild-type vs hereditary transthyretin amyloidosis in Crete
2026-01-100
PRE
Familial Hidradenitis Suppurativa on the Island of Crete: Distinct Patterns in Clinical Characteristics

克里特岛家族性化脓性汗腺炎:临床特征的独特模式

2025-10-011
PRE
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trial

设备检测到房颤且具有多种卒中风险因素患者的抗凝治疗效应:NOAH-AFNET 6试验的胜率分析

2025-09-012
OAAI
Deterioration of Myocardial Global Longitudinal Strain and Its Relationship with Arterial Stiffness in Patients with Cardiac Amyloidosis: A Six-Month Follow-Up
2025-03-180
OAAI
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: dThe NOAH-AFNET 6 Trial
2024-09-038
OAAI
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials

有或没有血管疾病的装置检测到的心房颤动的抗凝治疗: noah-afnet 6和ARTESiA试验的联合分析

2024-09-021
OAAI
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial
2024-04-095
OAAI
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 h
2023-11-1225
OAAI
Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes

心房高速率发作患者的依多沙班抗凝治疗

2023-09-28157
OA